Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.550
+0.110 (2.48%)
At close: Nov 3, 2026, 4:00 PM EST
4.580
+0.030 (0.66%)
Pre-market: Nov 4, 2026, 4:05 AM EST
Prime Medicine Revenue
Prime Medicine had revenue of $1.15M in the quarter ending June 30, 2026, with 3.50% growth. This brings the company's total for the last twelve months to $4.07M, down -17.90% year-over-year. In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth. That makes Prime Medicine the 40,621st largest company in the world by revenue and 5,424th in the United States.
Revenue (ttm)
$4.07M
Revenue Growth
-17.90%
P/S Ratio
198.74
Revenue / Employee
$27,897
Employees
146
Market Cap
809.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.63M | 1.65M | 55.28% |
| Dec 31, 2024 | 2.98M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Arbutus Biopharma | 181.72M |
| OmniAb | 40.21M |
| Aktis Oncology | 10.06M |
| Alumis | 7.40M |
| SL Science Holding | 3.27M |
PRME News
- 19 days ago - Prime Drink Group Announces Subscription Receipt Financing and Closing of Second Tranche of Private Placement of Units - Business Wire
- 4 weeks ago - Prime Medicine doses first patient in PM577a trial - TheFly
- 4 weeks ago - Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease - GlobeNewsWire
- 4 weeks ago - Prime Medicine Slides: Corporate presentation - Filings
- 5 weeks ago - Prime Medicine announces FDA clearance of IND application for PM647 - TheFly
- 5 weeks ago - Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 6 weeks ago - Prime Medicine Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Prime Medicine Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts